Matthew Porteus's most recent trade in Graphite Bio Inc was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 19, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Graphite Bio Inc | Matthew Porteus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Graphite Bio Inc | Matthew Porteus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |